GILEAD SCIENCES, INC. Quarterly Interest Expense in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Gilead Sciences, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q1 2024.
  • Gilead Sciences, Inc. Interest Expense for the quarter ending March 31, 2024 was $254M, a 10.4% increase year-over-year.
  • Gilead Sciences, Inc. Interest Expense for the twelve months ending March 31, 2024 was $968M, a 4.42% increase year-over-year.
  • Gilead Sciences, Inc. annual Interest Expense for 2023 was $944M, a 0.96% increase from 2022.
  • Gilead Sciences, Inc. annual Interest Expense for 2022 was $935M, a 6.59% decline from 2021.
  • Gilead Sciences, Inc. annual Interest Expense for 2021 was $1B, a 1.73% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $968M $254M +$24M +10.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $944M $252M +$26M +11.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $918M $232M +$3M +1.31% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $915M $230M -$12M -4.96% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $927M $230M -$8M -3.36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $935M $226M -$12M -5.04% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $947M $229M -$21M -8.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $968M $242M -$14M -5.47% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $982M $238M -$19M -7.39% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $1B $238M -$29M -10.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $1.03B $250M +$14M +5.93% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $1.02B $256M +$16M +6.67% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1B $257M +$16M +6.64% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $984M $267M +$24M +9.88% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $960M $236M -$14M -5.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $974M $240M -$8M -3.23% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $982M $241M -$13M -5.12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $995M $243M -$14M -5.45% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $1.01B $250M -$14M -5.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $1.02B $248M -$18M -6.77% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.04B $254M -$36M -12.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $1.08B $257M -$40M -13.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $1.12B $264M -$27M -9.28% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $1.14B $266M -$3M -1.12% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $1.15B $290M +$29M +11.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.12B $297M +$32M +12.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $1.09B $291M +$49M +20.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $1.04B $269M +$42M +18.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $995M $261M +$31M +13.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $964M $265M +$35M +15.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $929M $242M +$77M +46.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $852M $227M +$87M +62.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $765M $230M +$77M +50.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $688M $230M +$100M +76.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $588M $165M +$61M +58.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $527M $140M +$38M +37.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $489M $153M +$77M +101% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $412M $130M +$56.7M +77.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $355M $104M +$30.1M +40.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $325M $102M +$24M +30.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $301M $76M -$5.79M -7.08% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $307M $73.3M -$12.7M -14.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q3 2013 $320M $73.9M -$15.4M -17.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $335M $78M -$10.4M -11.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $346M $81.8M -$15.5M -15.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $361M $86M +$11M +14.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $350M $89.3M +$46.2M +107% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $304M $88.4M +$42.3M +91.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $261M $97.3M +$56.1M +136% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $205M $75M +$34.4M +84.6% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $171M $43.1M +$9.48M +28.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $162M $46.1M +$28.3M +160% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 $133M $41.2M +$24.3M +143% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $109M $40.6M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $33.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $17.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $17M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.